deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01282437

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC (NVALT11)

Prophylactic Cranial Irradiation (PCI) Versus Observation in Radically Treated Patients With Stage III Non-small Cell Lung Cancer; A Phase III Randomized Study.

Sponsor: Maastricht Radiation Oncology

Conditions Non Small Cell Lung Cancer (NSCLC) Radical Treatment Stage III Non-Small Cell Lung Cancer
Interventions Prophylactic Cranial Irradiation
Updated 5 times since 2017 Last updated: Apr 9, 2015 Started: Jan 31, 2009 Primary completion: Sep 30, 2014 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Non Small Cell Lung Cancer (NSCLC) and Radical Treatment and is currently completed. Maastricht Radiation Oncology leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maastricht Radiation Oncology
  • The Netherlands Cancer Institute
  • University Medical Center Groningen
Data source: Maastricht Radiation Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations